Shayna Sarosiek, MD, at #ASH23 discusses an ongoing clinical trial at Dana-Farber that uses rituximab and acalabrutinib to treat anti-MAG neuropathy, which occurs in some patients with IgM #MGUS or #Waldenstrom macroglobulinemia.
Dr. Sarosiek is actively involved in clinical research with her research efforts focused on the use of immunotherapies and antibody treatments in WM, as well as developing therapies and caring for those patients who have both WM and AL amyloidosis.
